chlordiazepoxide and mrk-409

chlordiazepoxide has been researched along with mrk-409 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atack, JR; Bormans, G; Burns, HD; Dawson, GR; de Hoon, JN; De Lepeleire, I; Hargreaves, RJ; McKernan, RM; Murphy, MG; Sanabria-Bohórquez, SM; Street, LJ; Tye, S; Van Hecken, A; Van Laere, K; Wafford, KA	1

Trials

1 trial(s) available for chlordiazepoxide and mrk-409

Article	Year
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:3 Topics: Adolescent; Adult; Animals; Anti-Anxiety Agents; Anxiety; Binding Sites; Brain; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; GABA-A Receptor Agonists; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrocarbons, Fluorinated; Male; Mice; Middle Aged; Positron-Emission Tomography; Protein Binding; Protein Subunits; Rats; Rats, Sprague-Dawley; Saimiri; Species Specificity; Tissue Distribution; Young Adult	2011

Article

Year

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.

Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:3

Topics: Adolescent; Adult; Animals; Anti-Anxiety Agents; Anxiety; Binding Sites; Brain; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; GABA-A Receptor Agonists; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrocarbons, Fluorinated; Male; Mice; Middle Aged; Positron-Emission Tomography; Protein Binding; Protein Subunits; Rats; Rats, Sprague-Dawley; Saimiri; Species Specificity; Tissue Distribution; Young Adult

2011